About Repair Biotechnologies
Repair Biotechnologies is a private company based in Syracuse, New York. It has reported $25,544,385 raised in eight offerings on Form D since August 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Nov 25, 2025 | $5,258,906of $11.0M target | 16 | $328K | EquityRule 506(b) | Form D ↗ |
| Mar 15, 2024 | Mar 26, 2024 | $6,166,000of $50.0M target | 7 | $880K | SAFEsRule 506(b) | Form D ↗ |
| Jun 2, 2023 | Jun 16, 2023 | $8,389,479of $8.6M target | 38 | $220K | EquityRule 506(b) | Form D ↗ |
| Feb 12, 2021 | Feb 23, 2021 | $200,000target not set | 2 | $100K | SAFE notesRule 506(b) | Form D ↗ |
| Aug 25, 2020 | Sep 1, 2020 | $2,855,000of $3.7M target | 13 | $219K | EquityRule 506(b) | Form D ↗ |
| Mar 11, 2019 | Mar 25, 2019amended May 7, 2019 | $2,150,000target not set | 15 | $143K | SAFE noteRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 14, 2019 | Jan 23, 2019 | $75,000fully sold | 1 | $75,000 | SAFE noteRule 506(b) | Form D ↗ |
| Jul 11, 2018 | Aug 21, 2018amended Aug 21, 2018 | $450,000of $550K target | 6 | $75,000 | SAFE noteRule 506(b) | Form D/A ↗1 earlier filing |
| Total, eight offerings | $25,544,385 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Repair Biotechnologies's Form D filed Nov 25, 2025.
GO
Guilherme Cherman Perdigao de Oliveira
Executive officer and director
KM
Kelsey Moody
Director
RE
Reason
Executive officer and director
Earlier filings also listed Guilherme Cherman Perdig?o de Oliveira (director, last listed Feb 2021), Anthony Chow (director, last listed Sep 2020) and Guilherme Oliveira (director, last listed May 2019).